PMS21 ABATACEPT OR INFLIXIMAB FOR RHEUMATOID ARTHRITIS IN VENEZUELA? A COST-EFFECTIVENESS ANALYSIS

Autor:	E.C. Aiello, N. Serra, Rafael Alfonso-Cristancho, C.N. Roa
Rok vydání:	2011
Předmět:	medicine.medical_specialty business.industry Health Policy Abatacept Public Health Environmental and Occupational Health Cost-effectiveness analysis medicine.disease Infliximab Internal medicine Rheumatoid arthritis medicine business health care economics and organizations medicine.drug
Zdroj:	Value in Health. 14:A126-A127
ISSN:	1098-3015
DOI:	10.1016/j.jval.2011.02.706
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dde8a72c67854880df45c517f1d197d4 https://doi.org/10.1016/j.jval.2011.02.706 Zobrazit plný text záznamu Full Text from ScienceDirect